End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
381,500.00 KRW | -4.15% | -3.90% | -0.78% |
Jan. 09 | Korea Zinc in talks with US buyers to supply antimony, chairman says | RE |
Jan. 07 | South Korea's FSS Refers Korea Zinc Execs to Prosecutors Over Alleged Fraudulent Trading; Shares Dip 3% | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3,084B | 3,183B | 3,582B | 4,429B | 3,762B | |||||
Other Revenues, Total | - | - | - | -10 | - | |||||
Total Revenues | 3,084B | 3,183B | 3,582B | 4,429B | 3,762B | |||||
Cost of Goods Sold, Total | 2,869B | 3,018B | 3,458B | 4,211B | 3,789B | |||||
Gross Profit | 215B | 166B | 125B | 218B | -26.86B | |||||
Selling General & Admin Expenses, Total | 125B | 114B | 146B | 142B | 134B | |||||
Provision for Bad Debts | 1.19B | 267M | 96.33M | 579M | -48.46M | |||||
R&D Expenses | - | - | - | 444M | 1.28B | |||||
Depreciation & Amortization - (IS) | 2.14B | 2.07B | 2.71B | 3.12B | 4.22B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 783M | 547M | 849M | 752M | 620M | |||||
Other Operating Expenses | 2.69B | 1.66B | 1.9B | 1.94B | 2.84B | |||||
Other Operating Expenses, Total | 132B | 119B | 151B | 149B | 143B | |||||
Operating Income | 83.5B | 46.84B | -26.91B | 68.83B | -170B | |||||
Interest Expense, Total | -12.9B | -5.7B | -4.74B | -8.98B | -18.88B | |||||
Interest And Investment Income | 9.41B | 8.49B | 7.92B | 14.19B | 25.18B | |||||
Net Interest Expenses | -3.49B | 2.79B | 3.17B | 5.21B | 6.3B | |||||
Income (Loss) On Equity Invest. | 181B | 166B | 238B | 235B | 162B | |||||
Currency Exchange Gains (Loss) | 1.97B | -9.54B | 14.79B | -720M | 7.76B | |||||
Other Non Operating Income (Expenses) | 4.68B | -7.31B | -26.86B | -14.67B | 6.31B | |||||
EBT, Excl. Unusual Items | 267B | 198B | 203B | 294B | 12.71B | |||||
Gain (Loss) On Sale Of Investments | - | 156M | 119M | -288M | 666M | |||||
Gain (Loss) On Sale Of Assets | -9.15B | -2.51B | -3.66B | -2.66B | -2.3B | |||||
Asset Writedown | -10.32B | -42.17B | 322M | -44.77B | -114B | |||||
Insurance Settlements | - | - | 1.44B | 1.06B | - | |||||
EBT, Incl. Unusual Items | 248B | 154B | 201B | 247B | -103B | |||||
Income Tax Expense | 40.43B | 68.47B | 30.69B | -169B | -19.23B | |||||
Earnings From Continuing Operations | 207B | 85.35B | 170B | 416B | -83.37B | |||||
Net Income to Company | 207B | 85.35B | 170B | 416B | -83.37B | |||||
Minority Interest | 25.63B | 47.29B | -45.89B | -48.4B | 22.51B | |||||
Net Income - (IS) | 233B | 133B | 124B | 367B | -60.86B | |||||
Net Income to Common Incl Extra Items | 233B | 133B | 124B | 367B | -60.86B | |||||
Net Income to Common Excl. Extra Items | 233B | 133B | 124B | 367B | -60.86B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 131K | 74.5K | 69.75K | 206K | -34.19K | |||||
Basic EPS - Continuing Operations | 131K | 74.5K | 69.75K | 206K | -34.19K | |||||
Basic Weighted Average Shares Outstanding | 1.78M | 1.78M | 1.78M | 1.78M | 1.78M | |||||
Net EPS - Diluted | 131K | 74.5K | 69.75K | 206K | -34.19K | |||||
Diluted EPS - Continuing Operations | 131K | 74.5K | 69.75K | 206K | -34.19K | |||||
Diluted Weighted Average Shares Outstanding | 1.78M | 1.78M | 1.78M | 1.78M | 1.78M | |||||
Normalized Basic EPS | 108K | 96.19K | 45.32K | 75.92K | 17.1K | |||||
Normalized Diluted EPS | 108K | 96.19K | 45.32K | 75.92K | 17.1K | |||||
Dividend Per Share | 9.66K | 9.66K | 9.66K | 9.66K | 9.66K | |||||
Payout Ratio | 7.38 | 12.97 | 13.85 | 4.68 | -28.26 | |||||
Supplemental Items | ||||||||||
EBITDA | 253B | 189B | 77.33B | 191B | -18.2B | |||||
EBITA | 84.65B | 48.09B | -25.74B | 69.88B | -169B | |||||
EBIT | 83.5B | 46.84B | -26.91B | 68.83B | -170B | |||||
EBITDAR | 257B | 192B | 79.92B | 194B | -14.04B | |||||
Effective Tax Rate - (Ratio) | 16.31 | 44.51 | 15.29 | -68.22 | 18.74 | |||||
Normalized Net Income | 193B | 171B | 80.69B | 135B | 30.45B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 860M | 534M | 858M | 866M | 677M | |||||
Selling and Marketing Expenses | 70.06B | 60.25B | 92.18B | 67.27B | 70.06B | |||||
General and Administrative Expenses | 3.25B | 2.64B | 2.61B | 10.45B | 1.68B | |||||
Research And Development Expense From Footnotes | - | - | - | 444M | 1.28B | |||||
Net Rental Expense, Total | 4.1B | 2.76B | 2.59B | 2.87B | 4.15B | |||||
Imputed Operating Lease Interest Expense | 1.63B | 508M | 306M | 545M | 1.55B | |||||
Imputed Operating Lease Depreciation | 2.47B | 2.26B | 2.28B | 2.33B | 2.6B | |||||
Maintenance & Repair Expenses, Total | 2.31B | 1.91B | 1.88B | 1.68B | 915M |